Physiological Regulation of MLCK in Intact Arteries
完整动脉中 MLCK 的生理调节
基本信息
- 批准号:7888764
- 负责人:
- 金额:$ 37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-22 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAccountingAcetatesAdrenergic ReceptorAffectAnimalsArteriesBiosensorBlood PressureCaliberCalmodulinContractsCoupledDOCADataDeoxycorticosteroneEndothelin-1EnzymesFluo 4Fluorescence Resonance Energy TransferFluorescent DyesFura-2FutureG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGenerationsGoalsHormonesHourHypertensionImageIntakeKnowledgeLifeLigandsMaintenanceMeasurementMeasuresMediatingMesenteryMicroscopeMicroscopyModelingMolecularMusMuscle functionMyosin Light Chain KinaseMyosin Light ChainsNa(+)-K(+)-Exchanging ATPaseNatriuretic FactorsNervous system structureOpticsPatternPerfusionPeripheral ResistancePhosphorylationPhysiologicalPhysiologyProcessReceptor ActivationRegulationRelative (related person)ReportingResearchRho-associated kinaseRoleSignal TransductionSmooth MuscleSodium ChlorideSpeedStagingStimulusTestingThreonineTimeTissuesTransgenic OrganismsVascular Smooth Muscleargipressin receptorbasedesignfluorescence imagingin vivomouse modelmyosin phosphatasepressurepublic health relevancereceptorresearch studyresponsesalt intakesensorvasoconstriction
项目摘要
DESCRIPTION (provided by applicant): Myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) are the major regulators of cross-bridge cycling and force generation in vascular smooth muscle. The overall goal of the proposed research is to gain new information on the role of these molecules (particularly MLCK) in controlling arterial contraction in normal function, and in a model of salt dependent hypertension (DOCA-salt model, deoxycorticosterone acetate and high dietary NaCl intake). Direct examination of MLCK activity in isolated arteries and in the arteries of living animals (i.e. in vivo) will be achieved through the use of (transgenic) 'biosensor' mice that express an optical (FRET) MLCK activity sensor. Regulation of MLCP in isolated arteries will be studied by quantifying threonine-855 phosphorylation of myosin phosphatase targeting subunit (MYPT1). Initial fluorescence imaging studies in isolated arteries (Aims 1 & 2) will reveal the activation of MLCK and regulation of MLCP in relation to 1) myogenic tone and 2) certain G-protein coupled receptors (GPCR) that are known to be important in hypertension. Myogenic tone (MT) is a key smooth muscle function that is involved in maintenance of arterial pressure, and in the response to tissue over-perfusion in initial stages of salt-induced hypertension. Therefore, Aim 1 is to quantify the dynamic and long-term (hours) activation of MLCK and regulation of MLCP as pressure is changed over the range of 10 to 150 mm Hg in isolated arteries. Aim 2 is to quantify MLCK activation, and MLCP inhibition, accomplished by two key classes of GPCR: 1) those coupled primarily to Gq/11, and 2) those also coupled strongly to G12/13. The latter have been implicated particularly in salt-induced hypertension and may utilize strong inhibition of MLCP, in addition to activation of MLCK. The influence of MT on GPCR induced signaling will also be studied since new data indicates that it affects contractile signaling of GPCR in ways not yet fully appreciated. Aim 3 will build on the knowledge gained in the isolated arteries , but will utilize in vivo imaging (i.e. intravital FRET microscopy) of arteries in anesthetized biosensor animals to quantify the role of MLCK in the increased vasoconstriction that occurs in DOCA-salt hypertension. In this final Aim, two current, competing, hypotheses will be examined: 1) that DOCA-salt hypertension is importantly maintained by circulating factors acting through G12/13 coupled GPCR and therefore involves strong inhibition of MLCP, rather than exclusive activation of MLCK, and 2) that salt-dependent hypertension involves mainly endogenous Na+ pump ligands (natriuretic factors) that contract smooth muscle by increasing [Ca2+] and thus act mainly through MLCK, rather than inhibition of MLCP. Summary: The research is intended to provide a detailed, quantitative, dynamic description of the activation and regulation of MLCK and MLCP in normal and hypertensive arteries in response to physiological stimuli, including transmural pressure and GPCR signaling. It will provide the first direct evidence, from arteries in the living animal, on the role of MLCK in salt-induced hypertension.
PUBLIC HEALTH RELEVANCE: The proposed research is intended to provide basic information on the activity and regulation of an enzyme (myosin light chain kinase, MLCK) that is critical to contraction of arteries, both in normal physiology and in high blood pressure (hypertension). Arteries exist in a contracted state in order to maintain blood pressure. The amount of contraction changes rapidly in response to activity of the nervous system and hormones. This research will utilize a mouse model of salt-induced hypertension to provide specific new information on the role of MLCK in high blood pressure.
描述(申请人提供):肌球蛋白轻链激酶(MLCK)和肌球蛋白轻链磷酸酶(MLCP)是血管平滑肌跨桥循环和力产生的主要调节因子。这项研究的总体目标是获得关于这些分子(特别是MLCK)在正常功能和盐依赖高血压模型(DOCA-盐模型、醋酸脱氧皮质酮和高食盐摄入量)控制动脉收缩中所起作用的新信息。通过使用表达光学(FRET)MLCK活性传感器的(转基因)‘生物传感器’小鼠,将实现对分离动脉和活体动物动脉中MLCK活性的直接检测。通过量化肌球蛋白磷酸酶靶向亚基(MYPT1)的苏氨酸-855磷酸化来研究MLCP在分离动脉中的调节。对分离动脉的初步荧光成像研究(AIMS 1和2)将揭示MLCK的激活和MLCP的调节与1)肌源性张力和2)某些已知在高血压中起重要作用的G蛋白偶联受体(GPCR)有关。肌张力(MT)是一种关键的平滑肌功能,它参与维持动脉压,并在盐诱导高血压的早期阶段对组织过度灌流做出反应。因此,目标1是量化MLCK的动态和长期(小时)激活,以及当压力在10-150毫米汞范围内变化时对MLCP的调节。目的2是为了定量MLCK的激活和MLCP的抑制,这是由两类关键的GPCR完成的:1)主要与GQ/11偶联的GPCR,以及2)与G12/13强偶联的GPCR。后者尤其与盐诱导的高血压有关,除了MLCK的激活外,可能还利用MLCP的强烈抑制。我们还将研究MT对GPCR诱导的信号转导的影响,因为新的数据表明,MT对GPCRs收缩信号的影响方式尚未完全被认识。目的3将建立在分离动脉获得的知识的基础上,但将利用麻醉生物传感器动物的动脉的活体成像(即活体FRET显微镜)来量化MLCK在DOCA-盐性高血压发生的血管收缩增加中的作用。在这个最终目标中,将检验两个目前相互竞争的假说:1)DOCA-盐高血压是由通过G12/13偶联GPCR作用的循环因子维持的,因此涉及对MLCP的强烈抑制,而不是唯一地激活MLCK;2)盐依赖型高血压主要涉及内源性钠泵配体(钠尿因子),它通过增加[Ca+]来收缩平滑肌,因此主要通过MLCK起作用,而不是抑制MLCP。摘要:本研究旨在提供一个详细的、定量的、动态的描述MLCK和MLCP在正常动脉和高血压动脉对生理刺激的反应的激活和调节,包括跨壁压力和GPCR信号。这将提供来自活体动物动脉的第一个关于MLCK在盐诱导的高血压中的作用的直接证据。
公共卫生相关性:这项拟议的研究旨在提供一种酶(肌球蛋白轻链激酶,MLCK)的活性和调节的基本信息,这种酶在正常生理和高血压(高血压)中对动脉收缩至关重要。动脉处于收缩状态是为了维持血压。收缩的量会随着神经系统和荷尔蒙的活动而迅速变化。这项研究将利用盐诱导高血压的小鼠模型来提供关于MLCK在高血压中作用的具体新信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Withrow Gil Wier其他文献
Sympathetically evoked Ca2+ signaling in arterial smooth muscle
动脉平滑肌中交感神经诱发的钙信号传导
- DOI:
10.1111/j.1745-7254.2006.00465.x - 发表时间:
2006-12-01 - 期刊:
- 影响因子:8.400
- 作者:
Wei-jin Zang;Joseph Zacharia;Christine Lamont;Withrow Gil Wier - 通讯作者:
Withrow Gil Wier
Withrow Gil Wier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Withrow Gil Wier', 18)}}的其他基金
Physiological Regulation of MLCK in Intact Arteries
完整动脉中 MLCK 的生理调节
- 批准号:
8235851 - 财政年份:2010
- 资助金额:
$ 37万 - 项目类别:
Physiological Regulation of MLCK in Intact Arteries
完整动脉中 MLCK 的生理调节
- 批准号:
8049063 - 财政年份:2010
- 资助金额:
$ 37万 - 项目类别:
Physiological Regulation of MLCK in Intact Arteries
完整动脉中 MLCK 的生理调节
- 批准号:
8432821 - 财政年份:2010
- 资助金额:
$ 37万 - 项目类别:
Sympathetic Neurotransmitters and Ouabain Hypertension
交感神经递质和哇巴因高血压
- 批准号:
6968175 - 财政年份:2004
- 资助金额:
$ 37万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 37万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:














{{item.name}}会员




